Homburger with ADC Therapeutics on shares placement
Homburger advised ADC Therapeutics on its USD 100 m Private Placement of Common Shares and Pre-Funded Warrants.
The context
Headquartered in Switzerland and listed on the NYSE under the ticker ADCT, ADC Therapeutics is a commercial-stage biotechnology company.
In connection with the operation, the company announced the private placement of 13.0 m common shares and pre-funded warrants to purchase 15.7 m common shares, raising aggregate gross proceeds of USD 100 m.
The Homburger team
Daniel Häusermann (corporate / M&A, capital markets, pictured) led the Homburger team on the matter, working alongside Bianca Nedwed and Estelle Piccard (both corporate / M&A, capital markets) as well as Stefan Oesterhelt and Philippe Weber (both tax).
